Latest period
$91M
YoY change
+12.2%
5Y CAGR
+7.1%
Peak year (FY2025)
$83M
Latest annual
$83M
Stock-Based Compensation history chart for Zoetis (ZTS) from 2016 to 2025
Latest: $83M
Stock-Based Compensation growth chart for Zoetis (ZTS) from 2016 to 2025
Latest: +12.2%
Stock-Based Compensation history table for Zoetis (ZTS) from 2009 to 2025
| FY2025 | $83M | +12.2% | +$9M | ||
| FY2024 | $74M | +23.3% | +$14M | ||
| FY2023 | $60M | -3.2% | -$2M | ||
| FY2022 | $62M | +6.9% | +$4M | ||
| FY2021 | $58M | -1.7% | -$1M | ||
| FY2020 | $59M | -11.9% | -$8M | ||
| FY2019 | $67M | +26.4% | +$14M | ||
| FY2018 | $53M | +20.5% | +$9M | ||
| FY2017 | $44M | +18.9% | +$7M | ||
| FY2016 | $37M | -14.0% | -$6M | ||
| FY2015 | $43M | +34.4% | +$11M | ||
| FY2014 | $32M | -25.6% | -$11M | ||
| FY2013 | $43M | +53.6% | +$15M | ||
| FY2012 | $28M | +47.4% | +$9M | ||
| FY2011 | $19M | +18.8% | +$3M | ||
| FY2010 | $16M | +6.7% | +$1M | ||
| FY2009 | $15M | — | — |
- FY2025$83M+12.2%
- FY2024$74M+23.3%
- FY2023$60M-3.2%
- FY2022$62M+6.9%
- FY2021$58M-1.7%
- FY2020$59M-11.9%
- FY2019$67M+26.4%
- FY2018$53M+20.5%
- FY2017$44M+18.9%
- FY2016$37M-14.0%
- FY2015$43M+34.4%
- FY2014$32M-25.6%
- FY2013$43M+53.6%
- FY2012$28M+47.4%
- FY2011$19M+18.8%
- FY2010$16M+6.7%
- FY2009$15M—
Stock-Based Compensation values are taken from Zoetis's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Stock-Based Compensation at Zoetis (ZTS)
Stock-Based Compensation for Zoetis (ZTS): headline value $91M · YoY +12.2%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Zoetis (ZTS) stock-based compensation totalled $83M – grew 12.2% year-over-year.
Through 2020–2025 (5 years), Zoetis stock-based compensation delivered a +7.1% annualised rate; with mixed annual results across the window.
$83M stands as the all-time-high annual stock-based compensation, posted in 2025, against a low of $15M during 2009.
Zoetis Stock-Based Compensation by Year
Zoetis Stock-Based Compensation 2025: $83M
Zoetis posted stock-based compensation of $83M in 2025, grew 12.2% from 2024. This figure represents the highest annual value in the available history.
Zoetis Stock-Based Compensation 2024: $74M
In 2024, Zoetis reported stock-based compensation of $74M, grew 23.3% from 2023.
Zoetis Stock-Based Compensation 2023: $60M
Zoetis stock-based compensation in 2023 was $60M, edged down 3.2% below 2022.
Zoetis Stock-Based Compensation 2022: $62M
2022's stock-based compensation for Zoetis came in at $62M, grew 6.9% from 2021.
Zoetis Stock-Based Compensation 2021: $58M
Zoetis stock-based compensation in 2021 was $58M.
See more financial history for Zoetis (ZTS).
Sector peers by Stock-Based Compensation
Healthcare peers of Zoetis (ZTS), ranked by their latest stock-based compensation
| $1.35B | |
| $971M | |
| $955M | |
| $626M | |
| $494M | |
| $310M | |
| $0.00 | |
| $0.00 |
- $1.35B
- $955M
- $626M
- $494M
- $0.00
- $0.00
Frequently asked questions
Zoetis (ZTS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.